Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List TICAGRELOR

TICAGRELOR synthesis

5synthesis methods
Ticagrelor, also known as AZD-6140 and AR-C 126532XX, is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved in 2011. Ticagrelor is an antagonist of the P2Y12 receptor. Like the thienopyridines prasugrel, clopidogrel and ticlopidine, ticagrelor blocks adenosine diphosphate (ADP) receptors of subtype P2Y12. In contrast to the other antiplatelet drugs, ticagrelor has a binding site different from ADP, making it an allosteric antagonist, and the blockage is reversible. Moreover, the drug does not need hepatic activation, which might work better for patients with genetic variants regarding the enzyme CYP2C19.
Synthetic Routes
  • ROUTE 1
  • 202112079167812821.jpg

    Zhang, Hao; Liu, Jun; Zhang, Luyong; Kong, Lingyi; Yao, Hequan; Sun, Hongbin. Synthesis and biological evaluation of ticagrelor derivatives as novel antiplatelet agents. Bioorganic & Medicinal Chemistry Letters. Volume 22. Issue 11. Pages 3598-3602. Journal; Online Computer File. (2012).

  • ROUTE 2
  • 202112074527846824.jpg

    Shimpi, Nitin A.; Prathi, Siva Koteswararao; Ponnuru, Anil Kumar; Batharaju, Ramesh; Dhake, Rajesh B. Novel synthetic methodology for the synthesis of Ticagrelor. Journal of Chemical and Pharmaceutical Research. Volume 8. Issue 1. Pages 797-803. Journal; Online Computer File. (2016).

  • ROUTE 3
  • 202112074579983307.jpg

    Anon. Crystalline intermediates of (1S, 2S, 3R, 5S)-3-[7-[[(1R, 2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5,d]pyrimidine-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol. IP.com Journal. Volume 13. Issue 6A. Pages 1-19. Journal; Patent. (2013).

  • ROUTE 4
  • 202112078872247190.jpg

    Canevotti, Renato; Della Negra, Federico; Mormile, Francesco; Previtali, Massimo; Rencurosi, Anna. Process for the preparation of triazolo[4,5-d]pyrimidinecyclopentane compounds. Assignee Flamma SpA, Italy. IT 1424427. (2016).

  • ROUTE 5
  • 202112077736215230.jpg

    Rasadia, Punitkumar Rameshbhai; Ramani, Vaibhav Narendrakumar; Shah, Anamik Kantilal; Pandey, Bipin. Processes for preparing triazolo-[4,5-d]-pyrimidines, including ticagrelor, via coupling of amines with nucleobases. Assignee Anlon Chemical Research Organization, India. IN 2014MU01457. (2015).

  • ROUTE 6
  • 202112073768001045.jpg

    She, Yang. Synthetic method of Ticagrelor. Assignee Suzhou Xinen Pharmaceutical Technology Co., Ltd., Peop. Rep. China. CN 107141298. (2017).

  • ROUTE 7
  • 202112073464113367.jpg

    Shatru, Ajat; Saini, Dharamvir; Sharma, Abhishek; Bhaskar, P. Muni; Srivastava, Alka; Vir, Dharam; Agarwal, Ashutosh. A process for the preparation of ticagrelor. IN 2014DE00882. (2016).

  • ROUTE 8
  • 202112079320600206.jpg

    Guile, Simon; Hardern, David; Ingall, Anthony; Springthorpe, Brian; Willis, Paul. Novel triazolo[4,5-d]pyrimidine compounds. Assignee AstraZeneca UK Limited, UK; AstraZeneca AB. WO 2000034283. (2000).

202112079167812821.jpg

Zhang, Hao; Liu, Jun; Zhang, Luyong; Kong, Lingyi; Yao, Hequan; Sun, Hongbin. Synthesis and biological evaluation of ticagrelor derivatives as novel antiplatelet agents. Bioorganic & Medicinal Chemistry Letters. Volume 22. Issue 11. Pages 3598-3602. Journal; Online Computer File. (2012).

274693-26-4 Synthesis
2-[[(3aS,4R,6S,6aR)-4-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]oxy]ethanol

274693-26-4
165 suppliers
inquiry

-

Yield:274693-27-5 97.1%

Reaction Conditions:

with hydrogenchloride in methanol at -3 - 20; for 3 h;Large scale;

Steps:

3 Example 3 Preparation of ticagrelor

Methanol (105 L) and Stage II (21 kg) were charged to the reaction kettle at room temperature,Cool to -3 ° C at -3 ° CConcentrate hydrochloric acid (107.1 kg) in batches in two hours and below,Stir for 1 hour. Methyl tert-butyl ether was charged to the reaction vessel at -3 ° C105L,207 L sodium hydroxide solution was added to adjust the pH of the reaction mass to 8.0. After the reaction mass was stirred at 10 ° C for 30 minutes,Warm to room temperature and stir for another 30 minutes.Static stratification,The organic and aqueous phases are separated,The lower aqueous phase was extracted with methyl tert-butyl ether,The organic phase was washed with saturated sodium chloride solution and then extracted with methanol.Combined organic phase,Put into activated carbon 2.10kg,Heated to 40 ° C,Stir for 30 minutes,filter,Rinse with methyl tert-butyl ether.Vacuum distillation,The resulting residue was recrystallized from ethyl acetate and cyclohexane,Centrifuge,Vacuum dried at 55 ° C for 6 hours,Ticagrelor.The yield is about 97.1%Purity is about 99.6%.

References:

CN106866682,2017,A Location in patent:Paragraph 0045; 0046; 0047; 0048

2-[[(3aR,4S,6R,6aS)-6-(7-azanyl-5-propylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol

1354945-69-9
30 suppliers
inquiry

1444301-72-7 Synthesis
[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]azanium:2-hydroxy-2-phenylacetate

1444301-72-7
2 suppliers
inquiry

TICAGRELOR Related Search: